Kyle Kostesich, Author at Atea Pharmaceuticals

Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19

Roche Obtains Exclusive Right to Develop and Distribute AT-527 Outside the United States BOSTON, Mass., October 22, 2020 – Atea Pharmaceuticals, Inc., a clinical… Read More

Atea Pharmaceuticals Appoints Polly Murphy, D.V.M, Ph.D., to the Board of Directors

Pharmaceutical executive brings 20 years of clinical, commercial and operational leadership BOSTON, Mass., September 14, 2020 – Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in… Read More